These consensus recommendations published in 2015 contain recommendations for the screening, investigation, diagnosis and management of non-tuberculous mycobacterial pulmonary disease in individuals with cystic fibrosis.
Current and future strategies, 2012
This document outlines the status of antibiotics for major airway pathogens, maintenance treatment for infection, diagnostic techniques and costeffectiveness analyses for antibiotic treatment of cystic fibrosis.
For additional information and a consensus document on antibiotic treatment in cystic fibrosis, visit the website below
This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.
Not a healthcare professional? Browse:
This global website is intended for healthcare professionals outside the UK, US and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.